Response to: Letter to the Editor with Regard to the Cost-Effectiveness of Hybrid Closed-Loop Systems Versus Multiple Daily Injections Plus Intermittently Scanned Continuous Glucose Monitoring in Type 1 Diabetes in the Netherlands

Levrat-Guillen F, De Cock P. Cost-effectiveness of hybrid closed-loop systems versus multiple daily injections plus intermittently-scanned continuous glucose monitoring in type 1 diabetes in the Netherlands: Comment on Serné et al. Adv Ther. 2022.

Choudhary P, Kolassa R, Keuthage W, et al. Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study. Lancet Diabetes Endocrinol. 2022;10(10):720–31.

Article  CAS  PubMed  Google Scholar 

Akturk HK, Giordano D, Champakanath A, Brackett S, Garg S, Snell-Bergeon J. Long-term real-life glycaemic outcomes with a hybrid closed-loop system compared with sensor-augmented pump therapy in patients with type 1 diabetes. Diabetes Obes Metab. 2020;22(4):583–9.

Article  CAS  PubMed  Google Scholar 

Charleer S, Block CD, Huffel LV, et al. Quality of life and glucose control after 1 year of nationwide reimbursement of intermittently scanned continuous glucose monitoring in adults living with type 1 diabetes (FUTURE): a prospective observational real-world cohort study. Diabetes Care. 2020;43:389–97.

Article  PubMed  Google Scholar 

Wilmot EG, Leelarathna L, Evans ML, Neupane S, Rayman G, Lumley S. FLASH-UK randomised controlled trial. In: Diabetes UK professional conference 2022. 2022.

Fokkert M, van Dijk P, Edens M, et al. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). BMJ Open Diabetes Res Care. 2019;7:e000809.

Article  PubMed  PubMed Central  Google Scholar 

Cordero TL, Garg SK, Brazg R, et al. The effect of prior continuous glucose monitoring use on glycemic outcomes in the pivotal trial of the MiniMed™ 670G hybrid closed-loop system. Diabetes Technol Ther. 2017;19:749–52.

Article  PubMed  Google Scholar 

McAuley SA, Lee MH, Paldus B, et al. Six months of hybrid closed-loop versus manual insulin delivery with fingerprick blood glucose monitoring in adults with type 1 diabetes: a randomized, controlled trial. Diabetes Care. 2020;43:3024–33.

Article  CAS  PubMed  Google Scholar 

Lepore G, Scaranna C, Corsi A, Dodesini AR, Trevisan R. Switching from suspend-before-low insulin pump technology to a hybrid closed-loop system improves glucose control and reduces glucose variability: a retrospective observational case-control study. Diabetes Technol Ther. 2020;22(4):321–5.

Article  PubMed  Google Scholar 

Garg SK, Weinzimer SA, Tamborlane WV, et al. Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther. 2017;19:155–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carlson AL, Sherr JL, Shulman DI, et al. Safety and glycemic outcomes during the MiniMed™ advanced hybrid closed-loop system pivotal trial in adolescents and adults with type 1 diabetes. Diabetes Technol Ther. 2021. https://doi.org/10.1089/dia.2021.0319.

Article  PubMed  PubMed Central  Google Scholar 

Petrovski G, Al Khalaf F, Campbell J, et al. One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes. Acta Diabetol. 2021;58(2):207–13.

Article  CAS  PubMed  Google Scholar 

Levrat-Guillen F, Ghazi T. Cost-effectiveness of intermittently scanned continuous glucose monitoring versus advanced hybrid closed-loop systems in type 1 diabetes: comment on Jendle et al. Diabetes Ther. 2022;13(5):1121–3.

Article  PubMed  PubMed Central  Google Scholar 

Jendle J, Buompensiere MI, Holm AL, de Portu S, Malkin SJP, Cohen O. A response to: letter to the editor with regard to the cost-effectiveness of an advanced hybrid closed-loop system in people with type 1 diabetes: a health economic analysis in Sweden. Diabetes Ther. 2022;13(5):1125–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nørgaard K, Scaramuzza A, Bratina N, et al. Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study. Diabetes Technol Ther. 2013;15:273–80.

Article  PubMed  PubMed Central  Google Scholar 

Al Hayek AA, Robert AA, Al Dawish MA. Evaluation of FreeStyle libre flash glucose monitoring system on glycemic control, health-related quality of life, and fear of hypoglycemia in patients with type 1 diabetes. Clin Med Insights Endocrinol Diabetes. 2017;10(10):1179551417746957.

PubMed  PubMed Central  Google Scholar 

Visser MM, Charleer S, Fieuws S, et al. Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial. Lancet. 2021;397(10291):2275–83.

Article  CAS  PubMed  Google Scholar 

Anderbro T, Amsberg S, Adamson U, et al. Fear of hypoglycaemia in adults with type 1 diabetes. Diabet Med. 2010;27(10):1151–8.

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif